These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

Academy of Managed Care Pharmacy (AMCP) Annual Meeting

Nashville, TN Apr 13 - 16, 2026

Results 1

Poster Presentation | Apr 13, 2026

Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory (R/R) NPM1-Mutated Acute Myeloid Leukemia (AML) in the United States

Abraham I, et al.

View Material